A 52-year-old man with a 20-year history of type 2 diabetes and hypertension presents with acute anterior wall myocardial infarction. Autopsy reveals extensive atherosclerotic plaques in the coronary arteries. Regarding the histological features and risk factors of atherosclerosis in this patient, all of the following are true EXCEPT:

Question

Accepted Answer

B. Lipoprotein(a) [Lp(a)] levels are inversely correlated with atherosclerotic plaque burden and are protective against coronary artery disease. ## Atherosclerosis in Diabetes and Hypertension: Pathophysiology and Risk Factors ### Clinical Context This patient exemplifies accelerated atherosclerosis due to multiple risk factors. The question tests knowledge of: 1. How metabolic and hemodynamic factors promote atherosclerosis 2. Histological features of advanced plaques 3. The role of emerging risk factors like Lp(a) ### Correct Statements (Options 0, 1, 2) **Option 0: Diabetes and Glycated LDL** - Hyperglycemia promotes non-enzymatic glycation of LDL apolipoprotein B - Glycated LDL (glyLDL) is more atherogenic than native LDL - Enhanced uptake by macrophage scavenger receptors (SR-A, LOX-1) - Leads to accelerated foam cell formation and plaque progression - Diabetes also impairs HDL function and increases triglycerides - [cite:Robbins 10e Ch 11] **Option 1: Hypertension and Endothelial Dysfunction** - Chronic hypertension increases hemodynamic shear stress on endothelial cells - Leads to endothelial dysfunction: loss of vasodilation, increased permeability - Upregulation of adhesion molecules (VCAM-1, ICAM-1) - Increased transendothelial migration of lipoproteins and monocytes - Hypertension is a major independent risk factor for atherosclerosis **Option 2: Histology of Advanced Plaques** - **Lipid-rich necrotic core:** Contains cholesterol crystals, cellular debris, and oxidized lipids - **Fibrous cap:** Composed of smooth muscle cells, collagen (types I and III), and proteoglycans - **Shoulder regions:** Sites of plaque rupture; contain macrophages and inflammatory cells - This architecture is characteristic of vulnerable plaques prone to rupture - [cite:Robbins 10e Ch 11] ### The Incorrect Statement (Option 3) **Option 3: Lp(a) and Atherosclerotic Risk** - **This is FALSE.** Lp(a) levels are **POSITIVELY** (not inversely) correlated with atherosclerotic plaque burden - Lp(a) is an independent risk factor for premature coronary artery disease and myocardial infarction - High Lp(a) is **PROATHEROGENIC**, not protective - Lp(a) resembles LDL but contains apolipoprotein(a) linked to apoB-100 - Lp(a) impairs fibrinolysis (inhibits tissue plasminogen activator and urokinase plasminogen activator) - Promotes inflammation and smooth muscle cell proliferation - The question asks for the statement that is NOT true — this is the answer **Key Point:** Lp(a) is an **emerging, independent risk factor** for atherosclerosis and thrombotic events. It is NOT protective; elevated levels increase cardiovascular risk. **High-Yield:** Lp(a) is genetically determined (70% heritability) and is one of the few lipid parameters NOT significantly modified by diet or statins. It is increasingly recognized as a major risk factor in NEET PG and cardiology practice. ### Comparison: Protective vs. Proatherogenic Lipoproteins | Lipoprotein | Effect on Atherosclerosis | Mechanism | |-------------|---------------------------|----------| | **LDL** | Proatherogenic | Oxidation → scavenger receptor uptake → foam cells | | **Oxidized LDL (oxLDL)** | Highly proatherogenic | Direct macrophage uptake; inflammatory | | **Glycated LDL** | Proatherogenic | Enhanced scavenger receptor recognition (in diabetes) | | **HDL** | Antiatherogenic | Reverse cholesterol transport; antioxidant | | **Lp(a)** | **Proatherogenic** | Impairs fibrinolysis; pro-inflammatory; independent risk factor | | **VLDL/Triglycerides** | Proatherogenic | Remnant particles; endothelial dysfunction | ### Pathophysiology of Accelerated Atherosclerosis in This Patient ```mermaid flowchart TD A[Type 2 Diabetes]:::outcome --> B[Hyperglycemia]:::action B --> C[LDL Glycation]:::action C --> D[Enhanced Scavenger
Receptor Uptake]:::action D --> E[Foam Cell Formation]:::outcome F[Hypertension]:::outcome --> G[Increased Shear Stress]:::action G --> H[Endothelial Dysfunction]:::action H --> I[Increased Permeability
Upregulation of Adhesion Molecules]:::action I --> E J[High Lp(a)]:::outcome --> K[Impaired Fibrinolysis
Pro-inflammatory]:::action K --> L[Accelerated Plaque
Progression & Thrombosis]:::urgent E --> M[Advanced Atherosclerotic Plaque
Lipid Core + Fibrous Cap]:::outcome M --> N[Plaque Rupture
Acute MI]:::urgent ``` ### Risk Factor Summary for This Patient **Modifiable:** - Hyperglycemia (glycemic control) - Hypertension (antihypertensive therapy) - Dyslipidemia (statins, ezetimibe) **Non-modifiable:** - Age (52 years) - Lp(a) level (genetic; not significantly modified by standard therapies) - Duration of diabetes (20 years) **Mnemonic: CHADS for Atherosclerotic Risk Factors** - **C:** Cholesterol (LDL, Lp(a)) - **H:** Hypertension - **A:** Age - **D:** Diabetes - **S:** Smoking

Answer

A. Diabetes accelerates atherosclerosis by promoting glycation of LDL, which enhances its uptake by macrophages and foam cell formation

Answer

C. Advanced atherosclerotic plaques contain a lipid-rich necrotic core surrounded by a fibrous cap composed primarily of collagen and smooth muscle cells

Answer

D. Hypertension increases shear stress on the endothelium, leading to endothelial dysfunction and increased permeability to lipoproteins

Explanation

Atherosclerosis in Diabetes and Hypertension: Pathophysiology and Risk Factors

Clinical Context

Correct Statements (Options 0, 1, 2)

The Incorrect Statement (Option 3)

Comparison: Protective vs. Proatherogenic Lipoproteins

Pathophysiology of Accelerated Atherosclerosis in This Patient

Risk Factor Summary for This Patient

Practice similar questions

Join our NEET PG community

Lipoprotein	Effect on Atherosclerosis	Mechanism
LDL	Proatherogenic	Oxidation → scavenger receptor uptake → foam cells
Oxidized LDL (oxLDL)	Highly proatherogenic	Direct macrophage uptake; inflammatory
Glycated LDL	Proatherogenic	Enhanced scavenger receptor recognition (in diabetes)
HDL	Antiatherogenic	Reverse cholesterol transport; antioxidant
Lp(a)	Proatherogenic	Impairs fibrinolysis; pro-inflammatory; independent risk factor
VLDL/Triglycerides	Proatherogenic	Remnant particles; endothelial dysfunction